Tangier Disease

On- and Off-Target Pharmacology of Torcetrapib

(2012) Douglas G. Johns et al.   DRUGS

Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial

(2012) Thomas F. Lüscher et al.   EUROPEAN HEART JOURNAL

An ABCA1 truncation shows no dominant negative effect in a familial hypoalphalipoproteinemia pedigree with three ABCA1 mutations

(2011) Brie Sorrenson et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Investigational CETP antagonists for hyperlipidemia and atherosclerosis prevention

(2011) Cesare R Sirtori   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Impaired Insulin Secretion in Four Tangier Disease Patients with ABCA1 Mutations

(2011) Masahiro Koseki et al.   Journal of Atherosclerosis and Thrombosis

Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial

(2011) Zahi A Fayad et al.   LANCET

HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms

(2011) Mohamad Navab et al.   Nature Reviews Cardiology

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

(2011) Amit V. Khera et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apolipoprotein A-I Mimetic Peptides

(2010) Courtney B. Sherman et al.   Cardiology in Review

Reconstituted HDL in Acute Coronary Syndromes

(2010) Rémy Chenevard et al.   Cardiovascular Therapeutics

Multiple abnormally spliced ABCA1 mRNAs caused by a novel splice site mutation of ABCA1 gene in a patient with Tangier disease

(2010) Letizia Bocchi et al.   CLINICA CHIMICA ACTA

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

(2010) Christopher P. Cannon et al.   NEW ENGLAND JOURNAL OF MEDICINE

A novel missense mutation of ABCA1 in transmembrane α-helix in a Japanese patient with Tangier disease

(2009) Mizuho Maekawa et al.   ATHEROSCLEROSIS

HDL biogenesis and functions: Role of HDL quality and quantity in atherosclerosis

(2009) Eirini M. Tsompanidi et al.   ATHEROSCLEROSIS

Tangier Disease in Severely Progressive Coronary and Peripheral Artery Disease

(2009) Tiziana Sampietro et al.   CIRCULATION

A novel ABCA1 nonsense mutation, R1270X, in Tangier disease associated with an unrecognised bleeding tendency

(2009) Amanda J. Hooper et al.   CLINICA CHIMICA ACTA

Severe HDL deficiency due to novel defects in the ABCA1 transporter

(2009) L. Pisciotta et al.   JOURNAL OF INTERNAL MEDICINE

The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis

(2008) Daniel J. Rader et al.   JOURNAL OF LIPID RESEARCH